0001127602-22-028082.txt : 20221221
0001127602-22-028082.hdr.sgml : 20221221
20221221164102
ACCESSION NUMBER: 0001127602-22-028082
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221219
FILED AS OF DATE: 20221221
DATE AS OF CHANGE: 20221221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thackray Helen M.
CENTRAL INDEX KEY: 0001589725
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 221478879
MAIL ADDRESS:
STREET 1: C/O GLYCOMIMETICS, INC.
STREET 2: 401 PROFESSIONAL DRIVE, SUITE 250
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-12-19
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001589725
Thackray Helen M.
4505 EMPEROR BOULEVARD
SUITE 200
DURHAM
NC
27703
1
Chief R&D Officer
Common Stock
2022-12-19
4
A
0
81000
0
A
214275
D
Emp. Stock Option (Right to Buy)
10.63
2022-12-19
4
A
0
238000
0
A
2023-12-19
2032-12-19
Common Stock
238000
238000
D
Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.
/s/ Alane P. Barnes, by power of attorney
2022-12-21